MG
TMDX icon

Mather Group’s Transmedics TMDX Stock Holding History

Mather Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69K Buy
+17
New +$2.22K ﹤0.01% 1719
2025
Q1 		– Sell
-16
Closed -$998 – 1860
2024
Q4 		$998 Hold
16
– – ﹤0.01% 1614
2024
Q3 		$2.51K Buy
+16
New +$2.46K ﹤0.01% 1432

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mather Group's TMDX Position: Q1 2026 in Review

Mather Group opened a new position in Transmedics (TMDX) in Q1 2026: 17 shares worth $1.69K. The stake represents ﹤0.01% of the portfolio and ranks #1719 among its holdings. This is a return to the name: Mather Group previously reported a position in TMDX as recently as Q4 2024.

Mather Group first reported a position in TMDX in Q3 2024 and has held it in 3 quarters since. The position peaked at $2.51K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Mather Group held 17 shares of Transmedics worth $1.69K as of Q1 2026.
  • Transmedics was a new Mather Group position in Q1 2026.
  • Transmedics made up ﹤0.01% of Mather Group's portfolio in Q1 2026, its #1719 holding.
  • Mather Group first reported a position in Transmedics in Q3 2024 and has held it in 3 quarters since.
  • Mather Group's Transmedics position peaked at $2.51K in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.